by IBM Line of Business
> View this now
Published on: June 2008
Type of content: WHITE PAPER
Format:
Adobe Acrobat (.pdf)
Length: 20 pages
Price: FREE
Overview:
Large pharma companies consider R&D such a defining capability, they've been hesitant to move these activities outside the firm-much less offshore. This paper addresses new market forces that are compelling them to consider a range of alternatives, including outsourcing and offshore opportunities.
|
